Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39 (Q28574229)

31 January 2017

title

Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39 (English)

1 reference

31 January 2017

0 references

Fumika Sakaue

1

1 reference

31 January 2017

Taro Saito

2

1 reference

31 January 2017

Yutaka Sato

3

1 reference

31 January 2017

Akiko Asada

4

1 reference

31 January 2017

Koichi Ishiguro

5

1 reference

31 January 2017

Masato Hasegawa

6

1 reference

31 January 2017

Shin-ichi Hisanaga

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

9 September 2005

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

280

1 reference

31 January 2017

issue

36

1 reference

31 January 2017

page(s)

31522–31529

1 reference

The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau phosphorylation: physiological and pathological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Neurodegenerative tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau pathology in Alzheimer disease and other tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau is a candidate gene for chromosome 17 frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Proline-directed and non-proline-directed phosphorylation of PHF-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Autosomal dominant dementia with widespread neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Cdk5 is a key factor in tau aggregation and tangle formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

Neurobiology: p25 protein in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504792200

21 January 2018

Identifiers

DOI

10.1074/JBC.M504792200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017